Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SAN DIEGO, Aug. 8, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, today reported financial results for the second quarter ended June 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
